GPCR
Structure Therapeutics Inc. NASDAQ Listed Feb 3, 2023$44.51
-1.09%
vs $45.00
Mkt Cap $2.6B
52w Low $16.20
36.5% of range
52w High $93.79
50d MA $42.74
200d MA $48.21
P/E (TTM)
—
EV/EBITDA
—
P/B
1.7x
Debt/Equity
0.0x
ROE
-9.3%
P/FCF
-11.7x
RSI (14)
67.90
ATR (14)
$2.19
Beta
-1.25
50d MA
$42.74
200d MA
$48.21
Avg Volume
754.0K
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.
611 Gateway Boulevard · South San Francisco, CA 94080 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.39 | -0.35 | +10.3% | 39.15 | -2.5% | -0.1% | -2.0% | -1.3% | +0.6% | +4.6% | — |
| Feb 26, 2026 | AMC | -0.35 | -0.49 | -40.0% | 64.75 | -1.0% | -2.7% | -0.1% | +0.2% | +0.1% | -5.4% | — |
| Nov 6, 2025 | AMC | -0.36 | -0.37 | -2.8% | 33.47 | +0.7% | -1.9% | +3.2% | +2.9% | +3.0% | -2.6% | — |
| Aug 6, 2025 | AMC | -0.28 | -0.36 | -28.6% | 16.31 | +8.5% | -0.7% | +0.7% | +7.4% | +7.0% | +2.2% | — |
| May 8, 2025 | AMC | -0.24 | -0.27 | -12.5% | 26.82 | -0.6% | -4.7% | -3.7% | -3.0% | -0.3% | +2.6% | — |
| Feb 27, 2025 | AMC | -0.23 | -0.22 | +4.3% | 22.82 | +1.7% | +4.1% | -5.9% | +0.7% | +0.4% | +4.3% | — |
| Nov 13, 2024 | AMC | -0.19 | -0.20 | -5.3% | 36.37 | -1.0% | +3.6% | -9.3% | -7.1% | +3.2% | -0.2% | — |
| Aug 8, 2024 | AMC | -0.23 | -0.18 | +21.7% | 34.49 | +4.3% | -2.1% | -1.7% | +3.4% | +5.6% | +0.7% | — |
| May 9, 2024 | AMC | -0.21 | -0.19 | +9.5% | 38.65 | -4.5% | -7.3% | +0.5% | -0.8% | +1.0% | -0.5% | — |
| Mar 8, 2024 | AMC | -0.21 | -0.17 | +19.0% | 36.86 | +1.9% | -4.7% | +0.5% | -3.9% | +3.8% | +0.2% | — |
| Nov 14, 2023 | AMC | -0.29 | -0.62 | -113.8% | 53.59 | +0.9% | -9.8% | -0.8% | +12.1% | -0.6% | -4.0% | — |
| Aug 10, 2023 | AMC | -0.28 | -0.60 | -114.3% | 29.35 | -3.5% | -6.1% | -1.6% | +0.6% | -0.8% | +1.7% | — |
| May 11, 2023 | AMC | -0.41 | -0.25 | +39.0% | 25.00 | +1.5% | +5.6% | -1.5% | -5.0% | -6.0% | -3.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | Canaccord Genuity | Initiates | Buy | $101 | $45.49 | $45.79 | +0.7% | -0.4% | -3.9% | -5.0% | +0.2% | +1.8% |
| Mar 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $53.75 | $56.58 | +5.3% | +5.4% | -0.9% | -7.6% | -2.8% | -3.7% |
| Mar 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $62.98 | $61.88 | -1.7% | -0.1% | +0.2% | +0.1% | -5.4% | -3.3% |
| Feb 27 | Citizens | Maintains | Market Outperform → Market Outperform | — | $64.75 | $64.13 | -1.0% | -2.7% | -0.1% | +0.2% | +0.1% | -5.4% |
| Jan 22 | JP Morgan | Maintains | Overweight → Overweight | — | $93.79 | $93.79 | +0.0% | -2.0% | -1.6% | -0.9% | -0.1% | -0.5% |
| Jan 20 | Guggenheim | Maintains | Buy → Buy | — | $88.64 | $88.36 | -0.3% | +2.7% | +3.0% | -2.0% | -1.6% | -0.9% |
| Dec 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $62.45 | $66.03 | +5.7% | +4.0% | -2.6% | +12.7% | -2.2% | -1.9% |
| Dec 12 | Morgan Stanley | Maintains | Overweight → Overweight | — | $67.44 | $68.61 | +1.7% | -0.6% | -3.4% | -4.8% | -2.8% | +4.1% |
| Dec 12 | Citizens | Maintains | Market Outperform → Market Outperform | — | $67.44 | $68.61 | +1.7% | -0.6% | -3.4% | -4.8% | -2.8% | +4.1% |
| Dec 11 | Jefferies | Maintains | Buy → Buy | — | $68.94 | $69.30 | +0.5% | -2.2% | -0.6% | -3.4% | -4.8% | -2.8% |
| Dec 9 | Stifel | Maintains | Buy → Buy | — | $69.98 | $67.86 | -3.0% | -4.6% | +3.3% | -2.2% | -0.6% | -3.4% |
| Dec 9 | Clear Street | Maintains | Buy → Buy | — | $69.98 | $67.86 | -3.0% | -4.6% | +3.3% | -2.2% | -0.6% | -3.4% |
| Dec 9 | Citigroup | Maintains | Buy → Buy | — | $69.98 | $67.86 | -3.0% | -4.6% | +3.3% | -2.2% | -0.6% | -3.4% |
| Aug 7 | Guggenheim | Maintains | Buy → Buy | — | $16.31 | $17.69 | +8.5% | -0.7% | +0.7% | +7.4% | +7.0% | +2.2% |
| Aug 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.31 | $17.69 | +8.5% | -0.7% | +0.7% | +7.4% | +7.0% | +2.2% |
| Aug 7 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $16.31 | $17.69 | +8.5% | -0.7% | +0.7% | +7.4% | +7.0% | +2.2% |
| Jun 23 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $21.73 | $21.91 | +0.8% | +1.7% | +1.3% | -2.6% | -3.3% | +0.0% |
| Jun 23 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $21.73 | $21.91 | +0.8% | +1.7% | +1.3% | -2.6% | -3.3% | +0.0% |
| May 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $25.57 | $26.38 | +3.2% | -3.7% | -3.0% | -0.3% | +2.6% | +3.0% |
| Apr 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.10 | $23.17 | +0.3% | -0.3% | +1.2% | +1.4% | +0.4% | -0.5% |
| Feb 28 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $22.82 | $23.20 | +1.7% | +4.1% | -5.9% | +0.7% | +0.4% | +4.3% |
| Dec 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $29.97 | $30.79 | +2.7% | -6.9% | +2.4% | -1.2% | +4.6% | -1.7% |
| Dec 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $27.90 | $27.42 | -1.7% | +7.4% | -6.9% | +2.4% | -1.2% | +4.6% |
| Dec 18 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $31.48 | $29.60 | -6.0% | -11.4% | +7.4% | -6.9% | +2.4% | -1.2% |
| Sep 23 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $41.92 | $45.00 | +7.3% | +1.0% | +3.9% | -4.7% | -1.0% | +0.5% |
| Sep 16 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $40.84 | $40.63 | -0.5% | -2.1% | -3.9% | -0.5% | +1.3% | +8.2% |
| Sep 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $36.95 | $37.13 | +0.5% | -4.7% | -2.2% | +15.2% | +1.6% | +1.4% |
| Aug 19 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $37.12 | $37.23 | +0.3% | +8.0% | +0.4% | -1.6% | -1.2% | +1.6% |
| Aug 15 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $36.24 | $36.83 | +1.6% | +0.7% | +1.7% | +8.0% | +0.4% | -1.6% |
| Aug 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $34.49 | $35.97 | +4.3% | -2.1% | -1.7% | +3.4% | +5.6% | +0.7% |
| Jul 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $39.27 | $40.01 | +1.9% | +1.9% | -3.2% | -3.3% | +0.9% | -1.4% |
| Jun 20 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $47.52 | $46.91 | -1.3% | -1.6% | -2.5% | -4.1% | -8.5% | -5.2% |
| Jun 17 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $48.17 | $48.39 | +0.5% | +0.9% | -2.2% | -1.6% | -2.5% | -4.1% |
| Jun 7 | BMO Capital | Maintains | Outperform → Outperform | — | $55.63 | $55.66 | +0.1% | -4.6% | -0.3% | -5.4% | +3.9% | -0.7% |
| Jun 3 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $34.20 | $35.45 | +3.7% | +54.2% | +2.9% | +3.7% | -1.2% | -4.6% |
| May 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $38.65 | $36.92 | -4.5% | -7.3% | +0.5% | -0.8% | +1.0% | -0.5% |
| May 3 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $38.99 | $39.55 | +1.4% | +0.8% | +1.1% | -1.0% | -0.3% | -1.5% |
| Apr 18 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $37.07 | $36.93 | -0.4% | -2.4% | +0.5% | -0.9% | +0.2% | +0.9% |
| Mar 8 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $36.01 | $36.79 | +2.2% | +2.4% | -4.7% | +0.5% | -3.9% | +3.8% |
| Nov 20 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $53.77 | $54.67 | +1.7% | -0.6% | -4.0% | +0.1% | +0.3% | +1.7% |
| Nov 15 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $53.59 | $54.09 | +0.9% | -9.8% | -0.8% | +12.1% | -0.6% | -4.0% |
| Oct 27 | Piper Sandler | Maintains | Overweight → Overweight | — | $70.00 | $69.00 | -1.4% | -2.6% | +2.2% | +6.6% | -0.6% | -2.7% |
| Oct 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $67.61 | $68.85 | +1.8% | +3.5% | -2.6% | +2.2% | +6.6% | -0.6% |
| Oct 3 | BMO Capital | Maintains | Outperform → Outperform | — | $56.60 | $58.04 | +2.5% | +4.1% | -7.4% | +0.8% | +0.2% | +5.2% |
| Sep 29 | Jefferies | Maintains | Buy → Buy | — | $37.47 | $65.09 | +73.7% | +34.6% | +12.3% | +4.1% | -7.4% | +0.8% |
| Feb 28 | Jefferies | Maintains | Buy → Buy | — | $24.00 | $24.20 | +0.8% | +6.5% | -10.3% | -0.4% | +16.3% | -2.1% |
| Feb 28 | BMO Capital | Maintains | Outperform → Outperform | — | $24.00 | $24.20 | +0.8% | +6.5% | -10.3% | -0.4% | +16.3% | -2.1% |
| Feb 28 | Guggenheim | Maintains | Buy → Buy | — | $24.00 | $24.20 | +0.8% | +6.5% | -10.3% | -0.4% | +16.3% | -2.1% |
No insider trades available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 8,403,449 | $405M | Reduced | Mar 2026 |
| 2 | Avoro Capital Advisors Llc | 6,555,555 | $316M | — | Mar 2026 |
| 3 | Morgan Stanley | 4,175,668 | $290M | Added | Dec 2025 |
| 4 | Janus Henderson Group Plc | 5,354,981 | $258M | New | Mar 2026 |
| 5 | Principal Financial Group Inc | 1,284,210 | $89M | Added | Dec 2025 |
| 6 | Capitolis Liquid Global Markets Llc | 1,151,300 | $55M | Added | Mar 2026 |
| 7 | Deerfield Management Company, L.p. | 767,993 | $37M | — | Mar 2026 |
| 8 | Franklin Resources Inc | 531,595 | $26M | Reduced | Mar 2026 |
| 9 | Healthcare Of Ontario Pension Plan Trust Fund | 467,800 | $23M | — | Mar 2026 |
| 10 | Aberdeen Group Plc | 391,809 | $19M | Added | Mar 2026 |
| 11 | Bank Of America Corp /de/ | 227,132 | $11M | Added | Mar 2026 |
| 12 | Ubs Group Ag | 212,919 | $10M | Added | Mar 2026 |
| 13 | Jane Street Group, Llc | 147,217 | $10M | New | Dec 2025 |
| 14 | D.e. Shaw & Co | 204,790 | $10M | Added | Mar 2026 |
| 15 | Stempoint Capital Lp | 200,267 | $10M | New | Mar 2026 |
| 16 | Jpmorgan Chase & Co | 212,803 | $9M | Added | Mar 2026 |
| 17 | Woodline Partners Lp | 190,808 | $9M | Added | Mar 2026 |
| 18 | Two Sigma Investments, Lp | 181,415 | $9M | Added | Mar 2026 |
| 19 | Millennium Management | 168,931 | $8M | Added | Mar 2026 |
| 20 | Rhenman & Partners Asset Management Ab | 128,100 | $6M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.63B
Enterprise Value
$1.19B
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-11.37x
P/B
1.74x
P/S
—
P/FCF
-11.67x
EV/EBITDA
—
Shares Out
59.2M
Financials (TTM)
Revenue
$0
Net Income
-$170.6M
EBITDA
-$167.7M
Free Cash Flow
-$225.8M
Op Cash Flow
-$222.2M
EPS Basic
$-2.40
EPS Diluted
$-2.64
EPS Forward
$-1.50
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$1.58B
Total Liab.
$67.5M
Total Equity
$1.52B
Cash
$1.45B
LT Debt
$3.6M
Book Value/Sh
$25.62
Debt/Equity
0.00x
Current Ratio
24.81
Quick Ratio
24.81
Returns & Growth
ROE
-9.3%
ROA
-8.9%
ROIC
-18.9%
Rev Growth YoY
+0.0%
EPS Growth YoY
-2.6%
Price Returns
2W
-1.3%
1M
-5.1%
3M
-37.5%
6M
+9.9%
12M
+80.8%
Technicals
52W High
$93.79
52W Low
$16.20
50d MA
$42.74
200d MA
$48.21
RSI (14)
67.90
ATR (14)
$2.19
Beta
-1.25
Avg Volume
754K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$114.75
High
$145.00
Low
$90.00
Median
$113.50
Data updated apr 26, 2026 10:44am
· Source: financialmodelingprep.com